金币
UID188591
帖子
主题
积分472
注册时间2015-1-24
最后登录1970-1-1
听众
性别保密
|
欢迎您注册蒲公英
您需要 登录 才可以下载或查看,没有帐号?立即注册
x
看到法规有两处很不一致的地方,想问问大家都是怎么做的呀?如下:GMP指南第二版第13章制药用水、气体及实验室环境、人员的质量监测章节说:"为了避免样品中微生物变化,样品应尽快转移到微生物实验室。再传递和储存期间,样品避免过热(大于25℃)或过冷(小于8℃),样品检验前的储存时间间隔应有验证资料支撑。“
然而PDA TR69-biaoburden and biofilm management in pharmceutical manufacturing operations里说到“samples for microbiological analysis should be tested as soon as possible after collection. if it is not possible to test the sample within about two hours of collection, the sample should be held at a cold temperture(2-8℃) and tested within 24 hours of collection. Tracking of the sample time, transport, and storage conditions prior to testing should be documented (e.g., the temperature should be continuously moonitored and documented.)”
这两个储存条件刚好相反,大家拿到样品能再两小时内处理好样品吗?有没有做过验证的呀。储存条件是低温还是室温这里又是怎么理解的呢?谢谢解答
|
|